Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Taysha Gene Therapies, Inc.: Increased authorized shares of common stock from 200,000,000 to 400,000,000 (effective 2023-11-15).
- Change
- charter amendment
- Effective
- 2023-11-15
Exact text from the filing
On November 15, 2023, Taysha Gene Therapies, Inc. (the “ Company ”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended to date, to increase the authorized number of shares of the Company’s common stock from 200,000,000 shares to 400,000,000 shares.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Taysha Gene Therapies, Inc. shareholders approved Approval of an amendment to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000. at the 2023-11-15 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-11-15
Exact text from the filing
Proposal No. 1: Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of the Company's common stock from 200,000,000 to 400,000,000. The votes were cast as follows: Votes For Votes Against Abstained Amendment to effectuate an authorized shares increase 133,386,292 1,370,285 157,132
View on SEC.gov